Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction

被引:35
作者
Guazzi, Marco [1 ,2 ]
Naeije, Robert [3 ]
机构
[1] Univ Milan, Dept Biol Sci, Milan, Italy
[2] San Paolo Hosp, Cardiol Div, Milan, Italy
[3] Free Univ Brussels, Erasme Hosp, Brussels, Belgium
关键词
heart failure with preserved ejection fraction; phenotype; pulmonary hypertension; right heart; RIGHT-VENTRICULAR DYSFUNCTION; PULMONARY ARTERIAL-HYPERTENSION; INSTITUTE WORKING GROUP; EXERCISE CAPACITY; PHOSPHODIESTERASE-5; INHIBITION; TRICUSPID REGURGITATION; INVASIVE HEMODYNAMICS; CONTRACTILE FUNCTION; TAPSE/PASP RATIO; NATIONAL-HEART;
D O I
10.1161/CIRCHEARTFAILURE.120.007840
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The health burden of heart failure with preserved ejection fraction is increasingly recognized. Despite improvements in diagnostic algorithms and established knowledge on the clinical trajectory, effective treatment options for heart failure with preserved ejection fraction remain limited, mainly because of the high mechanistic heterogeneity. Diagnostic scores, big data, and phenomapping categorization are proposed as key steps needed for progress. In the meantime, advancements in imaging techniques combined to high-fidelity pressure signaling analysis have uncovered right ventricular dysfunction as a mediator of heart failure with preserved ejection fraction progression and as major independent determinant of poor outcome. This review summarizes the current understanding of the pathophysiology of right ventricular dysfunction in heart failure with preserved ejection fraction covering the different right heart phenotypes and offering perspectives on new treatments targeting the right ventricle in its function and geometry.
引用
收藏
页数:12
相关论文
共 88 条
[1]   Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension [J].
Agrawal, Vineet ;
Fortune, Niki ;
Yu, Sheeline ;
Fuentes, Julio ;
Shi, Fubiao ;
Nichols, David ;
Gleaves, Linda ;
Poovey, Emily ;
Wang, Thomas J. ;
Brittain, Evan L. ;
Collins, Sheila ;
West, James D. ;
Hemnes, Anna R. .
PULMONARY CIRCULATION, 2019, 9 (04)
[2]   REPLY: The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes [J].
Al-Naamani, Nadine ;
Preston, Ioana R. ;
Paulus, Jessica K. ;
Hill, Nicholas S. ;
Roberts, Kari E. .
JACC-HEART FAILURE, 2015, 3 (10) :846-846
[3]   Forgotten No More A Focused Update on the Right Ventricle in Cardiovascular Disease [J].
Amsallem, Myriam ;
Mercier, Olaf ;
Kobayashi, Yukari ;
Moneghetti, Kegan ;
Haddad, Francois .
JACC-HEART FAILURE, 2018, 6 (11) :891-903
[4]   Enhanced Pulmonary Vasodilator Reserve and Abnormal Right Ventricular Pulmonary Artery Coupling In Heart Failure With Preserved Ejection Fraction [J].
Andersen, Mads J. ;
Hwang, Seok-Jae ;
Kane, Garvan C. ;
Melenovsky, Vojtech ;
Olson, Thomas P. ;
Fetterly, Kenneth ;
Borlaug, Barry A. .
CIRCULATION-HEART FAILURE, 2015, 8 (03) :542-550
[5]   Reduced Right Ventricular Sarcomere Contractility in Heart Failure With Preserved Ejection Fraction and Severe Obesity [J].
Aslam, M. Imran ;
Hahn, Virginia S. ;
Jani, Vivek ;
Hsu, Steven ;
Sharma, Kavita ;
Kass, David A. .
CIRCULATION, 2021, 143 (09) :965-967
[6]   Clinical Outcome of Isolated Tricuspid Regurgitation in Patients with Preserved Left Ventricular Ejection Fraction and Pulmonary Hypertension [J].
Bar, Nir ;
Schwartz, Lorin Arie ;
Biner, Simon ;
Aviram, Galit ;
Ingbir, Meirav ;
Nachmany, Ido ;
Margolis, Gilad ;
Sadeh, Ben ;
Barashi, Rami ;
Keren, Gad ;
Topilsky, Yan .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2018, 31 (01) :34-41
[7]   Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction [J].
Bartko, Philipp E. ;
Hulsmann, Martin ;
Hung, Judy ;
Pavo, Noemi ;
Levine, Robert A. ;
Pibarot, Philippe ;
Vahanian, Alec ;
Stone, Gregg W. ;
Goliasch, Georg .
EUROPEAN HEART JOURNAL, 2020, 41 (29) :2799-+
[8]   Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study [J].
Belyavskiy, Evgeny ;
Ovchinnikov, Artem ;
Potekhina, Alexandra ;
Ageev, Fail ;
Edelmann, Frank .
BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
[9]   Mechanisms of heart failure in transthyretin vs. light chain amyloidosis [J].
Binder, Christina ;
Duca, Franz ;
Stelzer, Philipp Dominik ;
Nitsche, Christian ;
Rettl, Rene ;
Aschauer, Stefan ;
Kammerlander, Andreas A. ;
Binder, Thomas ;
Agis, Hermine ;
Kain, Renate ;
Hengstenberg, Christian ;
Mascherbauer, Julia ;
Bonderman, Diana .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 (05) :512-524
[10]   Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1) [J].
Bonderman, Diana ;
Pretsch, Ingrid ;
Steringer-Mascherbauer, Regina ;
Jansa, Pavel ;
Rosenkranz, Stephan ;
Tufaro, Caroline ;
Bojic, Andja ;
Lam, Carolyn S. P. ;
Frey, Reiner ;
Kilama, Michael Ochan ;
Unger, Sigrun ;
Roessig, Lothar ;
Lang, Irene M. .
CHEST, 2014, 146 (05) :1274-1285